ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Contemporary Costs Associated With Transcatheter Aortic Valve Replacement

Wednesday, September 23, 2015

Submitted by

Arie Blitz

Source

Source Name: Annals of Thoracic Surgery

Source URL: http://www.annalsthoracicsurgery.org/article/S0003-4975(15)01039-5/abstract

Author(s)

Gorav Ailawadi, MD, Damien J. LaPar, MD, MS∗†, Alan M. Speir, MD†, Ravi K. Ghanta, MD†, Leora T. Yarboro, MD†, Ivan K. Crosby, MD†, D. Scott Lim, MD, Mohammed A. Quader, MD†, Jeffrey B. Rich, MD†

The authors conducted a propensity-matched analysis of outcomes and costs associated with TAVR vs. SAVR procedures in patients considered either intermediate risk (STS PROM 4-8%) or high risk (STS PROM >8%) within the Commonwealth of Virginia. Although the incidence of major morbidity was higher and the length of stay was longer with SAVR, the mortality was higher for TAVR (10% vs. 6%, p<0.047). Importantly, the median total costs of the implant hospitalization were more than double for the TAVR group in comparison to the SAVR group ($69,921 vs. $33,598). Not surprisingly, the dominant cost driver for TAVR was the cost of the device, which accounted for 40% of the cost of the implant hospitalization.